MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
118.84%
Quick Ratio
118.84%
Cash Ratio
92.56%
Debt to Asset Ratio
51.99%
Unit: Thousand (K) dollars
Assets Breakdown
    • Equity method investment - at fa...
    • Cash
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Total pavmed stockholders equity...
    • Noncontrolling interests
    • Senior secured convertible notes...
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Cash
-
-
3,103
4,004
Accounts receivable
-
-
3
3
Cash
3,784
6,460
-
-
Accounts receivable
16
21
-
-
Prepaid expenses, deposits, and other current assets
1,058
933
1,085
1,481
Total current assets
4,858
7,414
4,191
5,488
Fixed assets, net
73
79
81
100
Operating lease right-of-use assets
1,738
1,872
2,131
2,256
Equity method investment - at fair value
33,494
35,998
31,615
35,998
Other assets
51
56
51
51
Total assets
40,214
45,419
38,069
43,893
Accounts payable
1,056
983
342
387
Accrued expenses and other current liabilities
2,462
2,093
2,660
2,777
Operating lease liabilities, current portion
570
588
557
542
Senior secured convertible notes - at fair value
0
0
6,900
6,800
Total current liabilities
4,088
3,664
10,459
10,506
Senior secured convertible notes - at fair value
15,100
14,900
-
-
Rights liability
321
345
-
-
Operating lease liabilities, less current portion
1,398
1,522
1,823
1,968
Total liabilities
20,907
20,431
12,282
12,474
Preferred stock, 0.001 par value. authorized, 20,000,000 shares series c convertible preferred stock, stated value 1,058 at september 30, 2025, and issued and outstanding of 3,081 shares at september 30, 2025 and no shares issued and outstanding as of december 31, 2024
-
-
3,260
3,260
Preferred stock, value-Series BConvertible Preferred Stock
-
-
3,575
3,487
Preferred stock-Series BPreferred Stock
3,850
3,757
-
-
Preferred stock, value-Series CConvertible Preferred Stock
-
-
20,492
21,083
Preferred stock-Series CPreferred Stock
0
0
-
-
Common stock, 0.001 par value. authorized, 25,000,000 shares (note 12) 6,269,418 and 927,934 shares outstanding as of june 30, 2026 and december 31, 2025, respectively
6
6
23
20
Additional paid-in capital
295,697
294,788
265,331
263,515
Accumulated deficit
-264,505
-259,028
-256,901
-250,575
Total pavmed stockholders equity (deficit)
35,048
39,523
32,520
37,530
Noncontrolling interests
-15,741
-14,535
-9,993
-9,371
Total stockholders equity (deficit)
19,307
24,988
22,527
28,159
Total liabilities and stockholders equity
40,214
45,419
38,069
43,893
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$3,784K (-5.49%↓ Y/Y)Prepaid expenses,deposits, and other...$1,058K (-28.56%↓ Y/Y)Accounts receivable$16K (433.33%↑ Y/Y)Equity methodinvestment - at fair value$33,494K (-6.96%↓ Y/Y)Total current assets$4,858K (-11.48%↓ Y/Y)Operating leaseright-of-use assets$1,738K (-22.96%↓ Y/Y)Fixed assets, net$73K (-27.00%↓ Y/Y)Other assets$51K (0.00%↑ Y/Y)Total assets$40,214K (-8.38%↓ Y/Y)Total liabilities andstockholders equity$40,214K (-8.38%↓ Y/Y)Total liabilities$20,907K (67.60%↑ Y/Y)Total stockholdersequity (deficit)$19,307K (-31.44%↓ Y/Y)Noncontrolling interests-$15,741K (-67.98%↓ Y/Y)Senior securedconvertible notes - at fair...$15,100K (122.06%↑ Y/Y)Total currentliabilities$4,088K (-61.09%↓ Y/Y)Operating leaseliabilities, less current...$1,398K (-28.96%↓ Y/Y)Rights liability$321K Total pavmedstockholders equity...$35,048K (-6.61%↓ Y/Y)Accumulated deficit-$264,505K (-5.56%↓ Y/Y)Accrued expenses andother current...$2,462K (-11.34%↓ Y/Y)Accounts payable$1,056K (172.87%↑ Y/Y)Operating leaseliabilities, current portion$570K (5.17%↑ Y/Y)Additional paid-in capital$295,697K (12.21%↑ Y/Y)Preferred stock-SeriesBPreferred Stock$3,850K Common stock, 0.001 parvalue. authorized,...$6K (-70.00%↓ Y/Y)

PAVmed Inc. (PAVM)

PAVmed Inc. (PAVM)